MedTrace Logo

Tobacco Treatment as Augmentation for Cognitive Processing Therapy for PTSD

NCT02012452 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2016-10-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine whether tobacco affects recovery from PTSD. There are 3 goals of the study; (1) to test if quitting tobacco prior to PTSD treatment affects treatment success, (2) to test how PTSD symptoms change in those who have quit tobacco compared to those who continue to use and (3) to explore how tobacco use and tobacco withdrawal symptoms change during PTSD treatment.

Conditions

Interventions

BEHAVIORAL

Tobacco treatment

participants will be provided contingency management and cognitive behavioral therapy to help them quit tobacco prior to PTSD treatment

BEHAVIORAL

Health Education

Participants will be provided education on a variety of health topics and will set health goals around each topic

Sponsors & Collaborators

  • VA Office of Research and Development

    lead FED

Principal Investigators

  • Sandra Japuntich, PhD · VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02012452 on ClinicalTrials.gov